#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Prophylaxis against transplant rejection Angiosarcoma non-metastatic Congenital growth hormone deficiency Dementia with Lewy bodies Congenital aplastic anaemia Oesophageal squamous cell carcinoma stage II Cutaneous lupus erythematosus Multifocal motor neuropathy Anti-myelin-associated glycoprotein antibodies positive Von Hippel-Lindau disease Oesophageal adenocarcinoma stage II Small cell lung cancer Astrocytoma PIK3CA-activated mutation Polyneuropathy More trials…

    Learn about Rare Diseases

    Rett syndrome – Life with Disease VEXAS syndrome Haemophilia B without inhibitors – Diagnostics Haemophagocytic lymphohistiocytosis IgA nephropathy – Diagnostics Mucopolysaccharidosis III – Trials in Disease Factor VIII deficiency – Treatment Epidermolysis bullosa – Trials in Disease Lennox-Gastaut syndrome – Trials in Disease Uterine leiomyosarcoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ads-013 Florbetaben (18F) Transpocart19 Carbidopa Cldn6 Car-T(A) Mva-209-Fsp-B1 VERCIRNON Ciprofloxacin Hydrochloride DCC-3084 Tebipenem Pivoxil Hydrobromide Hydrocortisone Hemisuccinate Octreotide Hydrochloride Citalopram Hydrochloride [18F]CPFPX Rugonersen Volrustomig Gemcitabine Esomeprazole Magnesium FRUQUINTINIB Deferoxamine More therapies…

    Learn about Your Condition

    Antithrombin III deficiency Craniopharyngioma Carpal tunnel syndrome Renal disorder Ovarian granulosa cell tumour Pemphigus Osteoporosis Exfoliation glaucoma Senile dementia Peripheral spondyloarthritis CDKL5 deficiency disorder Oral lichen planus Pulmonary resection Bartonellosis Short-bowel syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • A study of EP0031 and drug combination for patients with advanced cancers having changes in the RET gene

    Recruiting

    1 1 1 1
    Investigated Diseases:
    • Medullary thyroid cancer
    • Neoplasm malignant
    • Non-small cell lung cancer metastatic
    Investigated Drugs:
    • Ep0031
    • Carboplatin
    • Cisplatin
    France Germany Italy Poland Spain

  • A study comparing odronextamab combined with chemotherapy versus rituximab combined with chemotherapy in adults with previously untreated follicular lymphoma

    Recruiting

    3 1 1 1
    Investigated Drugs:
    • Cyclophosphamide
    • Doxorubicin Hydrochloride
    • Odronextamab
    Austria Belgium Czechia France Germany Italy +2

  • A study of long-term safety and effectiveness of denecimig in people with haemophilia A with or without inhibitors

    Recruiting

    3 1 1
    Investigated Diseases:
    • Haemophilia A with anti factor VIII
    • Factor VIII deficiency
    Austria Belgium Bulgaria Denmark France Germany +10

  • A Study Testing Brexpiprazole Given Once Weekly to Treat Sudden Worsening of Symptoms in Patients with Schizophrenia

    Recruiting

    3 1 1
    Investigated Diseases:
    • Schizophrenia
    Investigated Drugs:
    • Brexpiprazole Fumarate
    • Brexpiprazole
    Romania

  • A study using MPPF imaging to examine serotonin pathways in the brainstem of patients with Dravet Syndrome epilepsy

    Recruiting

    2 1 1
    Investigated Diseases:
    • Severe myoclonic epilepsy of infancy
    Investigated Drugs:
    • 4-Fluoro-N-[2-[4-(2-Methoxyphenyl)Piperazin-1-Yl]Ethyl]-N-Pyridin-2-Ylbenzamide
    France

  • Comparing Two Doses of Dexamethasone to Improve Quality of Life in Patients 60 Years and Older Having Total Hip Replacement Surgery

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hip arthroplasty
    Investigated Drugs:
    • Dexamethasone Sodium Phosphate
    Belgium
Previous Page
1 … 73 74 75 76 77 … 1,646
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!